Replies to post #23779 on $Bob's and Jbem's Bitchin' Bios

[buckiii2]

CATB. October 26, 2017 08:00 AM Eastern Daylight Time
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, today announced that CAT-5571, which restores host defense by activating autophagy, will be presented in a poster at the 31st Annual North American Cystic Fibrosis Conference (NACFC). NACFC is being held November 2 – November 4, 2017, in Indianapolis, IN, at the Indiana Convention Center.

A poster titled “CAT-5571 Improves the Clearance of Intracellular Burkholderia Cenocepacia from Primary Cystic Fibrosis Macrophages,” resulting from a collaboration between Catabasis and Dr. Amal Amer at Ohio State University, will be presented during Poster Session 1 on Thursday, November 2, 2017, from 11:15am – 1:45pm local time.